journal
https://read.qxmd.com/read/32952993/lipidomic-analysis-as-a-tool-for-identifying-susceptibility-to-various-skin-diseases
#21
REVIEW
Valeriy V Smirnov, Evgenii A Egorenkov, Tatiana N Myasnikova, Alexey E Petukhov, Vladimir I Gegechkori, Anna M Sukhanova, Galina V Ramenskaya
This review is about the significance of the use of lipidomic analysis for identifying susceptibility to skin diseases. Exactly this article describes the use of lipidomic analysis in different studies to detect abnormalities in the lipid composition of the skin to diagnose and prevent various dermatological diseases.
November 1, 2019: MedChemComm
https://read.qxmd.com/read/32346467/different-solid-forms-for-optimizing-route-of-administration-of-the-herpes-drug-pritelivir
#22
REVIEW
Helga Ruebsamen-Schaeff, Helmut Buschmann
Pritelivir (AIC316, BAY 57-1293) was discovered as a highly potent drug against herpes simplex viruses with a novel mode of action, i.e. inhibition of the viral helicase-primase. A side by side comparison of the oral form against Valtrex™ in patients with genital herpes, showed superiority in phase II testing for Pritelivir. A number of different solid forms have been generated for additional, e.g. systemic, or topical applications.
November 1, 2019: MedChemComm
https://read.qxmd.com/read/32280435/non-lethal-growth-inhibition-by-arresting-the-starch-utilization-system-of-clinically-relevant-human-isolates-of-bacteroides-dorei
#23
JOURNAL ARTICLE
Anthony D Santilli, Jordan T Russell, Eric W Triplett, Kristi J Whitehead, Daniel C Whitehead
We describe the inhibition of the starch utilization system (Sus) belonging to various strains of Bacteroides dorei in a non-lethal manner using the small molecule probe, acarbose. Concentrations of acarbose as low as 5 μM significantly impede the growth of B. dorei and increase the doubling time of cultures. The successful inhibition of this species of Bacteroides is relevant to several disease states including type I diabetes mellitus. This method continues to explore a new, potential route to intervene in illnesses associated with aberrant changes in the composition of the human gut microbiota through the strategic manipulation of its constituents...
November 1, 2019: MedChemComm
https://read.qxmd.com/read/32206238/methyl-sulfonamide-substituents-improve-the-pharmacokinetic-properties-of-bicyclic-2-pyridone-based-chlamydia-trachomatis-inhibitors
#24
JOURNAL ARTICLE
Martina Kulén, Carlos Núñez-Otero, Andrew G Cairns, Jim Silver, Anders E G Lindgren, Emma Wede, Pardeep Singh, Katarina Vielfort, Wael Bahnan, James A D Good, Richard Svensson, Sven Bergström, Åsa Gylfe, Fredrik Almqvist
Chlamydia trachomatis infections are a global health problem and new approaches to treat C. trachomatis with drugs of high specificity would be valuable. A library of substituted ring fused 2-pyridones has been synthesized and evaluated for their ability to attenuate C. trachomatis infectivity. In vivo pharmacokinetic studies were performed, with the best candidates demonstrating that a C8-methylsulfonamide substituent improved pharmacokinetic properties important for oral administration. C8-Methyl sulfonamide analogue 30 inhibited C...
November 1, 2019: MedChemComm
https://read.qxmd.com/read/32206237/small-antibacterial-molecules-highly-active-against-drug-resistant-staphylococcus-aureus
#25
JOURNAL ARTICLE
Rajib Dey, Kathakali De, Riya Mukherjee, Sreyan Ghosh, Jayanta Haldar
The rapid growth of antibiotic resistance in Staphylococcus aureus coupled with their biofilm forming ability has made the infections difficult to treat with conventional antibiotics. This has created a massive threat towards public health and is a huge concern worldwide. Aiming to address this challenging issue, herein we report a new class of small antibacterial molecules (SAMs) with high antibacterial activity against multidrug-resistant S. aureus . The design principle of the molecules was based on the variation of hydrophobic/hydrophilic balance through incorporation of two quaternary ammonium groups, ethanol moieties, non-peptidic amide bonds and aliphatic chains...
November 1, 2019: MedChemComm
https://read.qxmd.com/read/32206236/structural-modification-of-azolylacryloyl-derivatives-yields-a-novel-class-of-covalent-modifiers-of-hemoglobin-as-potential-antisickling-agents
#26
JOURNAL ARTICLE
A M Omar, T David, P P Pagare, M S Ghatge, Q Chen, A Mehta, Y Zhang, O Abdulmalik, A H Naghi, M E El-Araby, M K Safo
The intracellular polymerization and the concomitant sickling processes, central to the pathology of sickle cell disease, can be mitigated by increasing the oxygen affinity of sickle hemoglobin (HbS). Attempts to develop azolylacryloyl derivatives to covalently interact with βCys93 and destabilize the low-O2 -affinity T-state (deoxygenated) HbS to the polymer resistant high-O2 -affinity R-state (liganded) HbS were only partially successful. This was likely due to the azolylacryloyls carboxylate moiety directing the compounds to also bind in the central water cavity of deoxygenated Hb and stabilizing the T-state...
November 1, 2019: MedChemComm
https://read.qxmd.com/read/32206235/druggability-profile-of-stilbene-derived-ppar-agonists-determination-of-physicochemical-properties-and-pampa-study
#27
JOURNAL ARTICLE
Pasquale Linciano, Barbara De Filippis, Alessandra Ammazzalorso, Pasquale Amoia, Felisa Cilurzo, Marialuigia Fantacuzzi, Letizia Giampietro, Cristina Maccallini, Charlotte Petit, Rosa Amoroso
PPAR agonists represent a new therapeutic opportunity for the prevention and treatment of neurodegenerative disorders, but their pharmacological success depends on favourable pharmacokinetic properties and capability to cross the BBB. In this study, we assayed some PPAR agonists previously synthesized by us for their physicochemical properties, with particular references to lipophilicity, solubility and permeability profiles, using the PAMPA. Although tested compounds showed high lipophilicity and low aqueous solubility, the results revealed a good overall druggability profile, encouraging further studies in the field of neurodegenerative diseases...
November 1, 2019: MedChemComm
https://read.qxmd.com/read/32133104/evaluation-of-anti-inflammatory-activity-and-molecular-docking-study-of-new-aza-bicyclic-isoxazoline-acylhydrazone-derivatives
#28
JOURNAL ARTICLE
Fernanda Virginia Barreto Mota, Marlene Saraiva de Araújo Neta, Eryvelton de Souza Franco, Isla Vanessa Gomes Alves Bastos, Larissa Cardoso Correia da Araújo, Sandra Cabral da Silva, Tatiane Bezerra de Oliveira, Eduarda Karynne Souza, Valderes Moraes de Almeida, Rafael Matos Ximenes, Maria Bernadete de Sousa Maia, Francisco Jaime Bezerra Mendonça Junior, Pascal Marchand, Antônio Rodolfo de Faria, Teresinha Gonçalves da Silva
The aim of this study was to investigate the anti-inflammatory effects of two new isoxazoline-acylhydrazone derivatives: N '-(4-methoxybenzylidene)-6-(4-nitro-benzoyl)-3 a ,5,6,6 a -tetrahydro-4 H -pyrrolo[3,2- d ]isoxazole-3-carbohydrazide (R-123) and N '-(4-chlorobenzylidene)-6-(4-chlorobenzoyl)-3 a ,5,6,6 a -tetrahydro-4 H -pyrrolo[3,2- d ]isoxazole-3-carbohydrazide (R-99). An air pouch induced by carrageenan was used for screening the best dose of R-99 and R-123. Using this mouse model, leukocyte migration and cytokine levels (TNF-α and IL-1β) were determined...
November 1, 2019: MedChemComm
https://read.qxmd.com/read/32180917/bim-46174-fragments-as-potential-ligands-of-g-proteins
#29
JOURNAL ARTICLE
Jim Küppers, Tobias Benkel, Suvi Annala, Gregor Schnakenburg, Evi Kostenis, Michael Gütschow
The 5,6,7,8-tetrahydroimidazo[1,2- a ]pyrazine derivative BIM-46174 has received attention as Gαq inhibitor. We conducted structural reductions to monocyclic and bicyclic substructures to explore the chemical space of BIM fragments and to gain insights into the pharmacophore of BIM-type Gαq inhibitors. Two piperazin-2-one-containing fragments and a small library of bicyclic lactams featuring fused pyrazine and diazepine rings were synthesized and evaluated. The results of a second messenger-based cellular assay indicate that the entire BIM structure is required for efficient Gαq inhibition...
October 1, 2019: MedChemComm
https://read.qxmd.com/read/32180916/development-of-hydroxamate-based-histone-deacetylase-inhibitors-of-bis-substituted-aromatic-amides-with-antitumor-activities
#30
JOURNAL ARTICLE
Di Ge, Lina Han, Feifei Yang, Na Zhao, Yang Yang, Hua Zhang, Yihua Chen
Previously, we designed and synthesized a series of bis-substituted aromatic amide-based histone deacetylase (HDAC) inhibitors. In this study, we report the replacement of a bromine atom by different amides on the phenyl ring of the CAP region. Representative compounds 9d and 10k exhibited low nanomolar IC50 values against HDAC1, which were ten times lower than that of the positive control SAHA. The IC50 of 9d against the human A549 cancer cell line was 2.13 μM. Furthermore, 9d increased the acetylation of histones H3 and H4 in a dose-dependent manner...
October 1, 2019: MedChemComm
https://read.qxmd.com/read/32180915/non-viral-transfection-vectors-are-hybrid-materials-the-way-forward
#31
REVIEW
A Gigante, M Li, S Junghänel, C Hirschhäuser, S Knauer, C Schmuck
Transfection is a process by which oligonucleotides (DNA or RNA) are delivered into living cells. This allows the synthesis of target proteins as well as their inhibition (gene silencing). However, oligonucleotides cannot cross the plasma membrane by themselves; therefore, efficient carriers are needed for successful gene delivery. Recombinant viruses are among the earliest described vectors. Unfortunately, they have severe drawbacks such as toxicity and immunogenicity. In this regard, the development of non-viral transfection vectors has attracted increasing interests, and has become an important field of research...
October 1, 2019: MedChemComm
https://read.qxmd.com/read/32055299/recent-advances-in-the-discovery-of-indoleamine-2-3-dioxygenase-1-ido1-inhibitors
#32
REVIEW
Xiu-Xiu Wang, Si-Yu Sun, Qing-Qing Dong, Xiao-Xiang Wu, Wei Tang, Ya-Qun Xing
Indoleamine 2,3-dioxygenase 1 (IDO1), an important immunoregulatory enzyme ubiquitously expressed in various tissues and cells, plays a key role in tryptophan metabolism via the kynurenine pathway and has emerged as an attractive therapeutic target for the treatment of cancer and other diseases, such as Alzheimer's disease and arthritis. IDO1 has diverse biological roles in immune suppression and tumor progression by tryptophan catabolism. In addition, IDO1-mediated immune tolerance assists tumor cells in escaping the immune surveillance...
October 1, 2019: MedChemComm
https://read.qxmd.com/read/31867093/developing-degraders-principles-and-perspectives-on-design-and-chemical-space
#33
JOURNAL ARTICLE
Hannah J Maple, Nat Clayden, Anne Baron, Callum Stacey, Robert Felix
Degraders ( e.g. PROTACs, SNIPERs, degronimers etc. ) are a new modality offering increasing potential both as tools for basic research and therapeutic development. They occupy chemical space that lies outside the classical Lipinski 'Rule of 5', which poses fresh challenges for achieving cell permeability and oral bioavailability. This study presents a comprehensive database of degrader structures from the peer reviewed literature, including both optimized degraders and first generation compounds, in order to provide a thorough assessment of the chemical space associated with this modality and identify common trends used during the 'hit to lead' process...
October 1, 2019: MedChemComm
https://read.qxmd.com/read/31814955/synergistic-effect-of-tolfenamic-acid-and-glycyrrhizic-acid-on-tpa-induced-skin-inflammation-in-mice
#34
JOURNAL ARTICLE
Wenfeng Liu, Shun Huang, Yonglian Li, Xi Zheng, Kun Zhang
Tolfenamic acid (TA) and glycyrrhizic acid (GA) are well-known components with anti-inflammatory properties. However, their combined effects on inflammation have not been well studied. The present study aimed to investigate the in vivo anti-inflammatory effects of TA combined with GA using a 12- O -tetradecanoylphorbol-13-acetate (TPA)-induced mouse ear edema model, as well as the underlying mechanisms thereof. The results indicated that TA combined with GA led to a stronger inhibition on TPA-induced mouse ear edema compared to the singular treatments...
October 1, 2019: MedChemComm
https://read.qxmd.com/read/31814954/structural-insights-and-binding-analysis-for-determining-the-molecular-bases-for-programmed-cell-death-protein-ligand-1-inhibition
#35
JOURNAL ARTICLE
Rita C Acúrcio, Carlota Leonardo-Sousa, Alfonso T García-Sosa, Jorge A Salvador, Helena F Florindo, Rita C Guedes
Programmed cell death protein 1 (PD-1) and PD-ligand 1 (PD-L1) interaction plays an important role in cancer immunotherapy. Several PD-1/PD-L1 inhibitors have been approved with remarkable impact on overall patient survival rates. Inhibitors in clinical practice are presently limited to monoclonal antibodies. However, their severe shortcomings expose the need for a new generation of PD-L1 inhibitors. Understanding the tumor microenvironment, identifying specific biomarkers and X-ray crystalline structures of PD-1/PD-L1 complexes, including molecular and genomic signature studies are essential to determine the success for the development of PD-1/PD-L1 inhibitors into safer and efficient cancer immunotherapeutics...
October 1, 2019: MedChemComm
https://read.qxmd.com/read/31814953/set-up-and-screening-of-a-fragment-library-targeting-the-14-3-3-protein-interface
#36
JOURNAL ARTICLE
Dario Valenti, João Filipe Neves, François-Xavier Cantrelle, Stanimira Hristeva, Domenico Lentini Santo, Tomáš Obšil, Xavier Hanoulle, Laura M Levy, Dimitrios Tzalis, Isabelle Landrieu, Christian Ottmann
Protein-protein interactions (PPIs) are at the core of regulation mechanisms in biological systems and consequently became an attractive target for therapeutic intervention. PPIs involving the adapter protein 14-3-3 are representative examples given the broad range of partner proteins forming a complex with one of its seven human isoforms. Given the challenges represented by the nature of these interactions, fragment-based approaches offer a valid alternative for the development of PPI modulators. After having assembled a fragment set tailored on PPIs' modulation, we started a screening campaign on the sigma isoform of 14-3-3 adapter proteins...
October 1, 2019: MedChemComm
https://read.qxmd.com/read/31814952/glycans-in-drug-discovery
#37
REVIEW
Pablo Valverde, Ana Ardá, Niels-Christian Reichardt, Jesús Jiménez-Barbero, Ana Gimeno
Glycans are key players in many biological processes. They are essential for protein folding and stability and act as recognition elements in cell-cell and cell-matrix interactions. Thus, being at the heart of medically relevant biological processes, glycans have come onto the scene and are considered hot spots for biomedical intervention. The progress in biophysical techniques allowing access to an increasing molecular and structural understanding of these processes has led to the development of effective therapeutics...
October 1, 2019: MedChemComm
https://read.qxmd.com/read/31803396/targeted-metabolomics-approach-for-identification-of-relapsing-remitting-multiple-sclerosis-markers-and-evaluation-of-diagnostic-models
#38
JOURNAL ARTICLE
Marat F Kasakin, Artem D Rogachev, Elena V Predtechenskaya, Vladimir J Zaigraev, Vladimir V Koval, Andrey G Pokrovsky
Multiple sclerosis (MS) is an inflammatory autoimmune disease that causes demyelination of nerve cell axons. This paper is devoted to the study of relapsing-remitting multiple sclerosis (RRMS) biomarkers using an LC-MS/MS-based targeted metabolomics approach and the assessment of changes in the profile of 13 amino acids and 29 acylcarnitines in plasma during the relapse of the disease. A significant increase ( p < 0.05) in the concentration of glutamate in plasma in patients with RRMS was detected, while the sum of leucine and isoleucine was reduced...
October 1, 2019: MedChemComm
https://read.qxmd.com/read/31803395/discovery-of-new-non-acidic-lonazolac-analogues-with-cox-2-selectivity-as-potent-anti-inflammatory-agents
#39
JOURNAL ARTICLE
Marwa F Harras, Rehab Sabour, Omkulthom Mohamed Alkamali
Herein, the design and synthesis of some novel 1,3,4-trisubstituted pyrazole derivatives was carried out through the structural modification of lonazolac. All the synthesized compounds were investigated for in vitro COX-1 & COX-2 inhibition and in vivo anti-inflammatory activity by a carrageenan rat paw edema model. Among them, the chalcones 2a and 2b were the most COX-2 selective derivatives (S.I. = 8.22 and 9.31, respectively) and revealed very good in vivo anti-inflammatory potency. Similarly, the compounds 4a , 6b , 7a and 8a exhibited good COX-2 selectivity and in vivo anti-inflammatory activity...
October 1, 2019: MedChemComm
https://read.qxmd.com/read/31803394/a-cell-based-screening-system-for-rna-polymerase-i-inhibitors
#40
JOURNAL ARTICLE
Xiao Tan, Samuel G Awuah
RNA polymerase I (RNA Pol I) is a "factory" that orchestrates the transcription of ribosomal RNA for constructing ribosomes as a primary workshop for protein translation to sustain cell growth. The deregulation of RNA Pol I often causes uncontrolled cell proliferation, leading to cancer. Efficient and reliable methods are needed for the identification of selective inhibitors of RNA Pol I. Yeast ( Saccharomyces cerevisiae ) is eukaryotic and represents a valuable model system to study RNA Pol I, especially with the availability of the X-ray crystal structure of the yeast homologue of RNA Pol I, offering a structural basis to selectively target this transcriptional machinery...
October 1, 2019: MedChemComm
journal
journal
43034
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.